Backed by Wing 2 Wing Ventures, Illuminant Surgical’s $8.4M seed round accelerates millimeter-accurate clinical guidance. Read the full news.
Crafting clear mission and vision statements is critical to shaping company identity, motivating employees and guiding decision-making. A mission statement defines the current scope and purpose of the ...
Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. I started with CNET reviewing ...
California-based Cognixion is launching a clinical trial to allow paralyzed patients with speech disorders the ability to communicate without an invasive brain implant. Cognixion is one of several ...
Npj Digital Surgery invites submissions for a special collection on Computer Vision in Surgical Practice. As surgical technology evolves, computer vision emerges as a powerful tool to enhance ...
The nature of scientific progress is that it sometimes provides powerful tools that can be wielded for good or for ill: splitting the atom and nuclear weapons being a case in point. In such cases, ...
Abstract: Tracheal intubation (TI) is a routine procedure in hospitals and is often life-saving for patients who need respiratory assistance. However, the current intubation approach requires the ...
Google has unveiled a new quantum computer and is once more claiming to have pulled ahead in the race to show that these exotic machines can beat even the world’s best conventional supercomputers – so ...
In critically ill patients, video laryngoscopy offers superior glottic visualization, reduces the incidence of esophageal intubation, and improves the first-attempt success rate of emergency tracheal ...
Big news dropped today for Vision Pro fans: Apple has reportedly halted plans for a Vision Pro 2. But that’s not the full story. Apple isn’t stopping development of the Vision Pro’s successor because ...
Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.
Marvel has tapped “Star Trek: Picard” executive producer Terry Matalas to resurrect Vision, the synthezoid played by Paul Bettany, for a new, untitled Disney+ series set for 2026, Variety has learned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results